FTSE Mondo Visione Exchanges Index:
News Centre
-
EBA Publishes Final Regulatory Products To Harmonise The Supervisory Review And Evaluation Process Of Investment Firms
Date 21/07/2022
The European Banking Authority (EBA) jointly with the European Securities and Markets Authority (ESMA), published today the final Guidelines on common procedures and methodologies for the supervisory review and evaluation process (SREP) for investment firms. The EBA published also the final draft Regulatory Technical Standards (RTS) on Pillar 2 add-ons for investment firms. Both regulatory products are based on the Investment Firms Directive (IFD) and aim to harmonise the supervisory practices regarding the supervisory review and evaluation process of investment firms.
-
ESMA Finds NCAs' Scrutiny And Approval Of Prospectuses Satisfactory
Date 21/07/2022
The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, is today publishing its Peer Review Report on the scrutiny and approval procedures of prospectuses by competent authorities. This peer review also assessed the impact of different approaches regarding scrutiny and approval by competent authorities on issuers’ ability to raise capital in the European Union.
-
The EBA Observes A Reduction Of High Earners In 2020 And A Slight Decrease Of Bonus Levels In The Context Of The COVID-19 Pandemic
Date 21/07/2022
The European Banking Authority (EBA) published today its Report on benchmarking of remuneration practices in EU banks for the financial years 2019 and 2020 and high earners data (EU27/EEA) for 2020. The number of high earners went down from 1 444 (EU27/EEA) or 4 963 (EU28/EEA) in 2019 to 1 383 (EU27/EEA) in 2020. While the bonus level for high earners remained relatively stable, a visible reduction can be observed for risk takers (identified staff).
-
Virax Biolabs Completes IPO - Shares Begin Trading Today On NASDAQ Capital Market As VRAX
Date 21/07/2022
Virax Biolabs Group Limited (“Virax” or the “Company”) (Nasdaq: VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today announced it has completed its initial public offering (IPO), and the Company’s shares began trading today on the Nasdaq Capital Market under the ticker symbol "VRAX."
-
SEC Charges Former Coinbase Manager, Two Others In Crypto Asset Insider Trading Action
Date 21/07/2022
The Securities and Exchange Commission today announced insider trading charges against a former Coinbase product manager, his brother, and his friend for perpetrating a scheme to trade ahead of multiple announcements regarding certain crypto assets that would be made available for trading on the Coinbase platform.
-
ACER: Conclusions Of The 2022 Roundtables On REMIT Data Reporting Are Now Available
Date 21/07/2022
The EU Agency for the Cooperation of Energy Regulators (ACER) publishes today the conclusions of the 2022 Roundtable meetings on REMIT data reporting and transparency of wholesale energy markets.
-
U.S. Office Of Financial Research: Three Insurance Industry Investment Trends To Watch
Date 21/07/2022
Today, the U.S. Office of Financial Research published a blog post discussing three insurance industry investment trends policymakers should watch.
-
CryptoCompare 2022 Outlook: Winter Is Here Q3 - A Catastrophic Quarter For Digital Assets
Date 21/07/2022
We are delighted to announce the release of CryptoCompare's latest research report - 2022 Q3 Outlook: Winter is Here.
-
ECB: Monetary Policy Decisions
Date 21/07/2022
Today, in line with the Governing Council’s strong commitment to its price stability mandate, the Governing Council took further key steps to make sure inflation returns to its 2% target over the medium term. The Governing Council decided to raise the three key ECB interest rates by 50 basis points and approved the Transmission Protection Instrument (TPI).
-
ICE Extends Climate Risk Management Offering With Acquisition Of Urgentem
Date 21/07/2022
- Adds transition risk data service and expands ICE’s coverage to over 30,000 public and private companies
- Supports TCFD Reporting Requirements
- First
- Previous
- 3369
- 3370
- 3371
- 3372
- 3373
- 3374
- 3375
- 3376
- 3377
- 3378
- 3379
- 3380
- 3381
- 3382
- 3383
- 3384
- 3385
- Next
- Last